Deferred Tax Assets, Valuation Allowance of AVAI BIO, INC. from 31 Mar 2018 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AVAI BIO, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2018 to 31 Mar 2025.
  • AVAI BIO, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2025 was $864,887, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

AVAI BIO, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $864,887 +$239,844 +38% 31 Mar 2025 10-K 08 Jul 2025 2025 FY
Q1 2024 $625,043 +$446,980 +251% 31 Mar 2024 10-K 08 Jul 2025 2025 FY
Q1 2023 $178,063 +$73,935 +71% 31 Mar 2023 10-K/A 19 Feb 2025 2024 FY
Q1 2022 $104,128 +$37,965 +57% 31 Mar 2022 10-K/A 13 Jul 2023 2022 FY
Q1 2021 $66,163 +$52,085 +370% 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q1 2020 $14,078 -$2,504 -15% 31 Mar 2020 10-K 13 Aug 2020 2020 FY
Q1 2019 $16,582 +$16,427 +10598% 31 Mar 2019 10-K 13 Aug 2020 2020 FY
Q2 2018 $1,302 30 Jun 2018 10-Q 25 Jul 2018 2019 Q1
Q1 2018 $155 31 Mar 2018 10-K 15 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.